Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Non-Current Assets: 2009-2025

Historic Non-Current Assets for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to $153.7 million.

  • Lifecore Biomedical's Non-Current Assets fell 11.14% to $153.7 million in Q2 2025 from the same period last year, while for May 2025 it was $153.7 million, marking a year-over-year decrease of 11.14%. This contributed to the annual value of $153.7 million for FY2025, which is 11.14% down from last year.
  • As of FY2025, Lifecore Biomedical's Non-Current Assets stood at $153.7 million, which was down 11.14% from $172.9 million recorded in FY2024.
  • Lifecore Biomedical's Non-Current Assets' 5-year high stood at $356.6 million during FY2021, with a 5-year trough of $153.7 million in FY2025.
  • Over the past 3 years, Lifecore Biomedical's median Non-Current Assets value was $159.7 million (recorded in 2023), while the average stood at $162.1 million.
  • As far as peak fluctuations go, Lifecore Biomedical's Non-Current Assets spiked by 161.44% in 2021, and later tumbled by 55.68% in 2022.
  • Lifecore Biomedical's Non-Current Assets (Yearly) stood at $356.6 million in 2021, then crashed by 55.68% to $158.0 million in 2022, then climbed by 1.03% to $159.7 million in 2023, then increased by 8.30% to $172.9 million in 2024, then decreased by 11.14% to $153.7 million in 2025.